Hyperfine, Inc.

Hyperfine, Inc. completed its de-SPAC transaction with HealthCor Catalio Acquisition Corp (Nasdaq: HCAQ), a blank-check company sponsored by HealthCor Catalio Sponsor, LLC that priced its initial public offering in 2021. The combination brought Hyperfine — a medical-technology company developing portable, low-field MRI devices — into the public markets, placing it in the healthcare technology and medical-device sector. The company filed an 8-K with the Securities and Exchange Commission on May 21, 2026, accession number 0001193125-26-234426, continuing its post-merger reporting obligations as a public registrant. For full filing history, transaction terms, and ongoing SPAC data on Hyperfine and hundreds of other deals, sign up for complete access at SpacDesk.